drug-induced liver injury
drug-induced liver injury
Explore linked clinical trials. Standard reference: MONDO:000535918 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SAMe in Prevention of Oxaliplatin-associated Liver Injury | 5-fluorouracil toxicity, Chemically-Induced Disorders, Chemically-Induced Liver Toxicity, Digestive System Diseases, Digestive System Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, cardiovascular disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, drug-induced liver injury, hepatic veno-occlusive disease, intestinal disorder, liver disorder, neoplasm, poisoning, rectal disorder, vascular disorder | Not yet recruiting | Phase 2 | 2026-09-30 | NCT06258525 | |
| Misocholic Tablets for Non-Viral Elevated Liver Enzymes | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, poisoning | Not yet recruiting | Phase 3 | 2026-09-22 | NCT07833514 | |
| Prevalence and Prognosis of Drug-Induced Liver Injury | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Hepatic Insufficiency, acute liver failure, drug-induced liver injury, liver disorder, liver failure, poisoning | Not yet recruiting | Not stated | 2026-09-21 | NCT07830901 | |
| Drug-induced Liver Injury: Itching Study | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, drug-induced liver injury, liver disorder, poisoning, skin disorder | Recruiting | Not stated | 2026-07-27 | NCT06446609 | |
| Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, bile duct disorder, biliary tract disorder, cholangitis, drug-induced liver injury, hepatitis, liver disorder, poisoning | Recruiting | Not stated | 2026-06-18 | NCT06864481 | |
| Drug-Induced Liver Injury (DILI) Network Retrospective | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2026-04-08 | NCT00360646 | |
| A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Not yet recruiting | Not stated | 2026-03-17 | NCT07476885 | |
| Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, drug-induced liver injury, gram-positive bacterial infections, latent tuberculosis infection, liver disorder, mycobacterial infectious disease, poisoning, tuberculosis | Not yet recruiting | Not stated | 2026-03-16 | NCT07472348 | |
| Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, drug-induced liver injury, hyperbilirubinemia, liver disorder, liver failure, poisoning | Recruiting | Not applicable | 2025-12-18 | NCT06922669 | |
| A Prognostic Model for Drug-induced Liver Injury in China | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2025-09-22 | NCT05060289 | |
| Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Infections, bacterial infectious disease, drug-induced liver injury, gram-positive bacterial infections, liver disorder, mycobacterial infectious disease, poisoning, tuberculosis | Not yet recruiting | Phase 1 | 2025-07-10 | NCT07058090 | |
| A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Active, not recruiting | Not stated | 2025-05-04 | NCT06670391 | |
| A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P） | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2025-05-04 | NCT02961413 | |
| Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Hepatic Insufficiency, acute liver failure, drug-induced liver injury, liver disorder, liver failure, poisoning | Active, not recruiting | Not applicable | 2025-03-12 | NCT06872372 | |
| Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2025-02-26 | NCT04964310 | |
| Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Not yet recruiting | Phase 2 / Phase 3 | 2025-01-28 | NCT06797011 | |
| Prospective Comparative Validation Study of RUCAM and RECAM | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2025-01-13 | NCT06771011 | |
| Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury | Chemically-Induced Disorders, Digestive System Diseases, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease susceptibility, drug-induced liver injury, inherited disease susceptibility, liver disorder, poisoning | Active, not recruiting | Not stated | 2024-08-12 | NCT06547229 |